Cardioverter-defibrillator having a focused shocking area and orientation thereof

• US 7,039,459 B2
• Filed: 11/05/2001
• Issued: 05/02/2006
• Est. Priority Date: 09/18/2000
• Status: Expired due to Term

• Current Assignee: Cameron Incorporated (Schlumberger NV)
• Original Assignee: Cameron Incorporated (Schlumberger NV)
• Inventors: Rissmann, William J., Bardy, Gust H., Sanders, Gary H., Cappato, Riccardo
• Primary Examiner(s): Schaetzle, Kennedy
• Assistant Examiner(s): Mullen, Kristen
• Application Number:
  US10/011,947
• Publication Number:
  US 20020107548A1
• Time in Patent Office: 1,639 Days
• Field of Search: 607 4- 5, 607/36
• US Class Current: 607/5
• CPC Class Codes: A61N 1/375 Constructional arrangements, e.g. casings
• CPC Class Codes: A61N 1/37512 Pacemakers
• CPC Class Codes: A61N 1/37518 Anchoring of the implants, e.g. fixation
• CPC Class Codes: A61N 1/3756 Casings with electrodes thereon, e.g. leadless stimulators
• CPC Class Codes: A61N 1/3906 characterised by the form of the shockwave
• CPC Class Codes: A61N 1/3956 Implantable devices for applying electric shocks to the heart, e.g. for cardioversion
• CPC Class Codes: A61N 1/3968 Constructional arrangements, e.g. casings A61N1/375 takes precedence
• CPC Class Codes: A61N 1/3975 Power supply A61N1/378 takes precedence

Abstract

One embodiment of the present invention provides an implantable cardioverter defibrillator for subcutaneous positioning between the third rib and the twelfth rib within a patient, the implantable cardioverter-defibrillator including a housing; an electrical circuit located within the housing; a first electrode coupled to the electrical circuit and located on the housing; and a second electrode coupled to the electrical circuit.

Claims

1. A method of inserting an implantable cardioverter-defibrillator within a patient, the method comprising the steps of:

providing a cardioverter-defibrillator comprising a housing, an electrical circuit located within the housing, a first subcutaneous electrode located on the housing, and a second subcutaneous electrode spaced from the housing;

making a single incision into the patient;

advancing the housing through the single incision and subcutaneously over approximately the anterior portion of a patient'"'"'s ribcage;

advancing the second subcutaneous electrode through the single incision and subcutaneously over the patient'"'"'s ribcage; and

orienting the second electrode such that it is substantially positioned in the range of approximately 30 degrees to approximately 180 degrees with respect to the patient'"'"'s heart, from the first electrode.

2. The method of claim 1, wherein the first electrode can emit an effective field strength for shocking the patient'"'"'s heart.

3. The method of claim 2, wherein the effective field strength for shocking the patient'"'"'s heart is approximately 0.5 J to approximately 350 J.

4. The method of claim 3, wherein the effective field strength for shocking the patient'"'"'s heart is approximately 0.5 J to approximately 25 J.

5. The method of claim 3, wherein the effective field strength for shocking the patient'"'"'s heart is approximately 150 J to approximately 200 J.

6. The method of claim 3, wherein the effective field strength for shocking the patient'"'"'s heart is approximately 200 J to approximately 250 J.

7. The method of claim 3, wherein the effective field strength for shocking the patient'"'"'s heart is approximately 250 J to approximately 300 J.

8. The method of claim 3, wherein the effective field strength for shocking the patient'"'"'s heart is approximately 300 J to approximately 350 J.

9. The method of claim 1, wherein the first electrode is less than approximately 5000 square millimeters in area.

10. The method of claim 9, wherein the first electrode is approximately 2000 square millimeters to approximately 2500 square millimeters.

11. The method of claim 9, wherein the first electrode is between approximately 2500 square millimeters and 3000 square millimeters.

12. The method of claim 9, wherein the first electrode is between approximately 3000 square millimeters and 3500 square millimeters.

13. The method of claim 9, wherein the first electrode is between approximately 3500 square millimeters and 4000 square millimeters.

14. The method of claim 9, wherein the first electrode is between approximately 4000 square millimeters and 4500 square millimeters.

15. The method of claim 9, wherein the first electrode is between approximately 4500 square millimeters and 5000 square millimeters.

16. The method of claim 1, further including positioning the implantable cardioverter-defibrillator subcutaneously between the third and fifth ribs.

17. The method of claim 1, further including positioning the implantable cardioverter-defibrillator subcutaneously between the fourth and sixth ribs.

18. The method of claim 1, further including positioning the implantable cardioverter-defibrillator subcutaneously between the sixth and eighth ribs.

19. The method of claim 1, further including positioning the implantable cardioverter-defibrillator subcutaneously between the eight and tenth ribs.

20. The method of claim 1, further including positioning the implantable cardioverter-defibrillator subcutaneously between the tenth and twelfth ribs.

21. The method of claim 1, further including positioning the implantable cardioverter-defibrillator such that it provides anti-tachycardia pacing energy to the heart for treatment of atrial fibrillation.

22. The method of claim 1, further including positioning the implantable cardioverter-defibrillator such that it provides anti-tachycardia pacing energy to the heart for treatment of ventricular tachycardia.

23. An implantable cardioverter defibrillator for subcutaneous positioning between the third rib and the twelfth rib within a patient, the implantable cardioverter-defibrillator comprising:

a housing;

an electrical circuit located within the housing;

a first electrode coupled to the electrical circuit; and

a second electrode coupled to the electrical circuit, wherein the second electrode is positioned approximately 30 degrees to approximately 180 degrees, with respect to the patient'"'"'s heart, apart from the first electrode;

wherein the first electrode is contained within a single face of the housing, the face of the housing being concave;

wherein the first electrode emits and focuses an effective field strength through the patient'"'"'s heart to shock the heart.

24. The implantable cardioverter-defibrillator of claim 23, wherein the effective field strength for shocking the patient'"'"'s heart is approximately 0.5 J to approximately 350 J.

25. The implantable cardioverter-defibrillator of claim 23, wherein the effective field strength for shocking the patient'"'"'s heart is approximately 0.5 J to approximately 25 J.

26. The implantable cardioverter-defibrillator of claim 24, wherein the effective field strength for shocking the patient'"'"'s heart is approximately 150 J to approximately 200 J.

27. The implantable cardioverter-defibrillator of claim 24, wherein the effective field strength for shocking the patient'"'"'s heart is approximately 200 J to approximately 250 J.

28. The implantable cardioverter-defibrillator of claim 24, wherein the effective field strength for shocking the patient'"'"'s heart is approximately 250 J to approximately 300 J.

29. The implantable cardioverter-defibrillator of claim 24, wherein the effective field strength for shocking the patient'"'"'s heart is approximately 300 J to approximately 350 J.

30. The implantable cardioverter-defibrillator of claim 23, wherein the first electrode is less than approximately 5000 square millimeters in area.

31. The implantable cardioverter-defibrillator of claim 30, wherein the first electrode is approximately 2000 square millimeters to approximately 2500 square millimeters.

32. The implantable cardioverter-defibrillator of claim 30, wherein the first electrode is between approximately 2500 square millimeters and 3000 square millimeters.

33. The implantable cardioverter-defibrillator of claim 30, wherein the first electrode is between approximately 3000 square millimeters and 3500 square millimeters.

34. The implantable cardioverter-defibrillator of claim 30, wherein the first electrode is between approximately 3500 square millimeters and 4000 square millimeters.

35. The implantable cardioverter-defibrillator of claim 30, wherein the first electrode is between approximately 4000 square millimeters and 4500 square millimeters.

36. The implantable cardioverter-defibrillator of claim 30, wherein the first electrode is between approximately 4500 square millimeters and 5000 square millimeters.